Article Text

Download PDFPDF
Primary peritoneal carcinoma in a UK cancer center: comparison with advanced ovarian carcinoma over a 5-year period
  1. K. S. Jaaback*,
  2. L. Ludeman,
  3. N. L. Clayton and
  4. L. Hirschowitz
  1. * Departments of Obstetrics and Gynaecology, Royal United Hospital, Combe Park, Bath, United Kingdom
  2. Cellular Pathology, Royal United Hospital, Combe Park, Bath, United Kingdom
  3. School of Medical Sciences, University of Bristol, Bristol, United Kingdom
  1. Address correspondence and reprint requests to: Dr Lynn Hirschowitz, MBBCh, FRCPath, Department of Histopathology, Royal United Hospital, Bath BA1 3NG, United Kingdom. Email: lynn.hirschowitz{at}


The relative incidence of primary peritoneal carcinoma (PPCa) and advanced (FIGO stage III or IV) ovarian serous carcinoma (AOSCa) was assessed over 5 years at a UK cancer center, and the sociodemographic, clinical, and survival data were compared. There were 23 women with PPCa and 55 with AOSCa. The ratio of PPCa:AOSCa was higher than previously reported. No statistical difference was found between the two groups with regard to age (mean 64.43 vs 64.07 years, P= 0.9), parity (1.6 vs 1.8, P= 1.0), personal/family history of another malignancy (although five patients with AOSCa but none with PPCa had personal histories of breast cancer), or serum CA125, CA19.9, and carcinoembryonic antigen (CEA) levels. Similar numbers in both groups had malignant ascites, although 5.8% of patients with AOSCa but none with PPCa had negative cytology. Tumor grade, stage, treatment, and survival were similar (median 586 vs 641 days, P= 0.66). This analysis of the largest published UK series of patients with PPCa does not support previous reports that patients with PPCa are older than those with AOSCa and have a worse prognosis; it suggests that both groups have similar sociodemographic characteristics, clinical profiles, and survival.

  • CA125
  • CA19.9
  • ovarian serous carcinoma
  • primary peritoneal carcinoma
  • survival

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.